In this ebook we share expert views and case studies on some of the hot topics in vaccine bioprocess development. We hope the information on viral vector production, continuous bioprocessing, and process scale-up will prove useful for your own development projects.
This eBook's collection of articles focuses on exciting developments in the field of cell therapy and many important considerations that can help you accelerate and achieve your cell therapy program goals.
In this ebook, sponsored by GE Healthcare, we dive into some of the current challenges that biomanufacturers face when analyzing their production streams for impurities and what they are doing to improve detection methodologies for HCPs.
The Cell Therapy market has been experiencing double-digit growth over the last 3-5 years and is anticipated to continue at this pace. This eBook, sponsored by Catalent, focuses on new cell therapy discoveries, subsequent manufacturing challenges, and solutions to efficiently scale to commercial-ready processes. As cell therapies make their way from discovery, development, clinical and commercial manufacturing, each step poses new challenges and consideration points.
Non-invasive, continuous live-cell imaging has the potential to provide deeper insight into the kinetics of cell health, morphology and function. This new eBook features a collection of must-read articles on real-time live-cell analysis.
The live-cell field is always evolving, and researchers need a way to stay up to date on new instruments, applications, assays, and reagents. In this GEN eBook, sponsored by Sartorius, we cover how live cell analysis attains dimension.
In this eBook we will bring you up to speed on all the new advances in western blotting such as stain-free technology, total protein normalization, 3 minute rapid transfer technique, 5 minute rapid universal blocking, and state-of-the-art advances in digital imaging.
In this eBook, sponsored by Origene, you will read about the fascinatingways bioengineering has changed how antibodymolecules are applied to research and the clinicalworld. Despite all the changes, specificity remainsthe core value determinant of an antibody, albeitnaturally or recombinantly made.
The drug development industry faces intense pressure to bring biologics and drugs to market more rapidly as well as to mitigate the risk of late-stage failure. Collapsing workflows can save days. This new eBook features a collection of must-read articles that review technological advantages of a high-throughput flow cytometry platform built for screening.
In this eBook, sponsored by Precision for Medicine, we explore timely topics in the diagnostics landscape, from regulatory considerations and next-generation COVID-19 diagnostics to an innovative next-generation sequencing initiative that will help fuel the next wave of biomarker-driven research and development.